抗核糖体抗体能改善系统性红斑狼疮的诊断吗?

IF 1.8 4区医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Medicc Review Pub Date : 2021-01-01 Epub Date: 2021-01-30 DOI:10.37757/MR2021.V23.N1.15

Elena Kokuina

{"title":"抗核糖体抗体能改善系统性红斑狼疮的诊断吗?","authors":"Elena Kokuina","doi":"10.37757/MR2021.V23.N1.15","DOIUrl":null,"url":null,"abstract":"Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The only means of reducing its morbidity and mortality remains early diagnosis followed by timely medical treatment. SLE affects all populations worldwide, although prevalence rates differ between population groups, with higher rates among women of reproductive age and for African, Asian, and Hispanic ethnicities.[1]","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"23 1","pages":"90-91"},"PeriodicalIF":1.8000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Can Anti-Ribosomal Antibodies Improve Systemic Lupus Erythematosus Diagnosis?\",\"authors\":\"Elena Kokuina\",\"doi\":\"10.37757/MR2021.V23.N1.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The only means of reducing its morbidity and mortality remains early diagnosis followed by timely medical treatment. SLE affects all populations worldwide, although prevalence rates differ between population groups, with higher rates among women of reproductive age and for African, Asian, and Hispanic ethnicities.[1]\",\"PeriodicalId\":49835,\"journal\":{\"name\":\"Medicc Review\",\"volume\":\"23 1\",\"pages\":\"90-91\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicc Review\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.37757/MR2021.V23.N1.15\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicc Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37757/MR2021.V23.N1.15","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Can Anti-Ribosomal Antibodies Improve Systemic Lupus Erythematosus Diagnosis?

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The only means of reducing its morbidity and mortality remains early diagnosis followed by timely medical treatment. SLE affects all populations worldwide, although prevalence rates differ between population groups, with higher rates among women of reproductive age and for African, Asian, and Hispanic ethnicities.[1]

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medicc Review PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

3.30

自引率

9.50%

发文量

审稿时长

>12 weeks

期刊介绍： Uphold the highest standards of ethics and excellence, publishing open-access articles in English relevant to global health equity that offer the best of medical, population health and social sciences research and perspectives by Cuban and other developing-country professionals.